Trials / Unknown
UnknownNCT03590236
Graded Exposure Therapy in Chronic Pelvic Pain
Graded Exposure Therapy in Women With Chronic Pelvic Pain
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Universidad de Granada · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Chronic pelvic pain (CPP) is considered as nonmalignant recurrent or continuous pain related to the structures of the pelvis. The objective of this study was to evaluate the effects of graded exposure therapy in women with chronic pelvic pain.
Detailed description
Chronic pelvic pain (CPP) is considered as nonmalignant recurrent or continuous pain related to the structures of the pelvis. This condition lasts at least 6 months, and many times is associated with negative cognitive, emotional, sexual and behavioral consequences.In addition to the high economic cost, CPP is also costly in emotional and psychological suffering. This clinical trial aims to evaluate the effects of a program based on graded exposure therapy in women with chronic pelvic pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Graded exposure therapy | Patients included in this group received graded exposure therapy consisting on counselling, a graded activity through postural exercises and individual training focused on 5 activities selected by the patients. The treatment will include 5 sessions added to the 12 sessions of physiotherapy. |
| OTHER | Physiotherapy | Physiotherapy intervention will include soft tissue mobilizations and myofascial release combined with deep-pressure massage to decrease trigger point-related pain and tension. In addition joint mobilization and muscle energy techniques will be included. |
Timeline
- Start date
- 2017-08-20
- Primary completion
- 2018-02-12
- Completion
- 2018-08-10
- First posted
- 2018-07-18
- Last updated
- 2018-07-18
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03590236. Inclusion in this directory is not an endorsement.